reMYND
Desconocido
PANA: PROMOTING ACTIVE AGEING FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER S DISEASE AT ULTRA EARLY STAGES.
reMYND NV
participó en un
H2020:
H2020-NMP-2014-2015
Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and...
2016-03-04 - 2021-08-31 | Financiado
2016-03-04 - 2021-08-31 | Financiado
NPLAST: NPlast A neuroscience school that aims to preserve and restore neuroplasticity in brain disorders
reMYND NV
participó en un
FP7:
Brain disorders impose an increasing economical and social burden in the member states of the European Union (EU). For most neurodegenerativ...
Financiado
Financiado
AGEDBRAINSYSBIO: SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING
reMYND NV
participó en un
FP7:
In spite of valuable approaches applied to get a broad understanding of genetic, epidemiologic and molecular and system-level biological pri...
Financiado
Financiado
* No se disponen de datos de la empresa actual.